A Randomized Placebo-controlled Study to Assess Safety and Preliminary Efficacy of BGP345A in Patients With Constipation Due to the Use of Opioid-based Medications for the Management of Chronic Non Cancer Pain
Latest Information Update: 03 Jul 2025
At a glance
- Drugs Limosilactobacillus reuteri (Primary)
- Indications Constipation
- Focus Therapeutic Use
- Acronyms OIC1
- Sponsors BioGaia
Most Recent Events
- 26 Jun 2025 Status changed from recruiting to completed.
- 13 Feb 2023 Planned End Date changed from 1 Jan 2023 to 1 Dec 2023.
- 13 Feb 2023 Planned primary completion date changed from 1 Jan 2023 to 1 Dec 2023.